Terms: = Liver cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Diagnosis
1922 results:
1. Early detection of HCC in patients with cirrhosis using AI; a Systematic Review.
Khursheed AA; Khan MR
J Pak Med Assoc; 2024 Apr; 74(4 (Supple-4)):S29-S36. PubMed ID: 38712406
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective clinical analysis of 11 cases of PEComa from different sites.
Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
[TBL] [Abstract] [Full Text] [Related]
3. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
Öztürk NB; Jamil LH
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
[TBL] [Abstract] [Full Text] [Related]
4. Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging.
Dong H; Yang L; Shaofeng D; Lili G
Technol Cancer Res Treat; 2024; 23():15330338241245943. PubMed ID: 38660703
[TBL] [Abstract] [Full Text] [Related]
5. Retrospective analysis of the incidence of appendiceal neoplasm and malignancy in patients treated for suspected acute appendicitis.
Dohner E; Kierdorf FJ; Langer R; Zuber M; Fahrner R
BMC Surg; 2024 Apr; 24(1):121. PubMed ID: 38658891
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
7. Multiscale and multiperception feature learning for pancreatic lesion detection based on noncontrast CT.
Yan T; Tang G; Zhang H; Liang L; Ma J; Gao Y; Zhou C; Li S
Phys Med Biol; 2024 May; 69(10):. PubMed ID: 38588676
[No Abstract] [Full Text] [Related]
8. UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.
Jalali P; Samii A; Rezaee M; Shahmoradi A; Pashizeh F; Salehi Z
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2032. PubMed ID: 38577722
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced liver MRI.
Yoon JH; Kim YK; Kim JW; Chang W; Choi JI; Park BJ; Choi JY; Kim SS; Park HS; Lee ES; Yu JS; Park SJ; You MW; Lee CH; Lee JM
Radiology; 2024 Apr; 311(1):e233114. PubMed ID: 38563667
[TBL] [Abstract] [Full Text] [Related]
10. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
[TBL] [Abstract] [Full Text] [Related]
11. Research on multi-model imaging machine learning for distinguishing early hepatocellular carcinoma.
Ma Y; Gong Y; Qiu Q; Ma C; Yu S
BMC Cancer; 2024 Mar; 24(1):363. PubMed ID: 38515051
[TBL] [Abstract] [Full Text] [Related]
12. Optimizing LI-RADS: ancillary features screened from LR-3/4 categories can improve the diagnosis of HCC on MRI.
Zhang ZX; Xv H; Du YN; Lv ZB; Yang ZH
BMC Gastroenterol; 2024 Mar; 24(1):117. PubMed ID: 38515017
[TBL] [Abstract] [Full Text] [Related]
13. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic cancer: A Multicenter Cohort Study.
Huang J; Gao G; Ge Y; Liu J; Cui H; Zheng R; Wang J; Wang S; Go VL; Hu S; Liu Y; Yang M; Sun Y; Shang D; Tian Y; Zhang Z; Xiang Z; Wang H; Guo J; Xiao GG
Dig Dis Sci; 2024 Apr; 69(4):1263-1273. PubMed ID: 38451429
[TBL] [Abstract] [Full Text] [Related]
14. The role of baseline 2-[
Albano D; Calabrò A; Dondi F; Bagnasco S; Tucci A; Bertagna F
Hematol Oncol; 2024 Mar; 42(2):e3266. PubMed ID: 38444261
[TBL] [Abstract] [Full Text] [Related]
15. Survival Among Patients With High-Risk Gastrointestinal cancers During the COVID-19 Pandemic.
Janczewski LM; Browner AE; Cotler JH; Palis BE; Chan K; Joung RH; Bentrem DJ; Merkow RP; Boffa DJ; Nelson H
JAMA Netw Open; 2024 Mar; 7(3):e240160. PubMed ID: 38441896
[TBL] [Abstract] [Full Text] [Related]
16. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
17. A Systematic Review and Meta-Analysis of MRI Radiomics for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma.
Zhou HY; Cheng JM; Chen TW; Zhang XM; Ou J; Cao JM; Li HJ
Curr Med Imaging; 2024; 20():1-11. PubMed ID: 38389371
[TBL] [Abstract] [Full Text] [Related]
18. Volatile organic compounds for diagnosis of early hepatocellular carcinoma in at-risk patients.
Sukaram T; Tansawat R; Phathong C; Rerknimitr R; Chaiteerakij R
Clin Chim Acta; 2024 Mar; 556():117831. PubMed ID: 38378104
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic accuracy of serum protein induced by vitamin K absence (PIVKA-II), serum a-fetoprotein and their combination for hepatocellular carcinoma among Caucasian cirrhotic patients with diagnostic or non-diagnostic serum a-fetoprotein levels.
Syriha A; Pantzios S; Mandilara D; Galanis P; Stathopoulou I; Barla G; Elefsiniotis I
Cancer Med; 2024 Feb; 13(3):e6825. PubMed ID: 38361401
[TBL] [Abstract] [Full Text] [Related]
20. Point-of-care diagnosis of tissue fibrosis: a review of advances in vibrational spectroscopy with machine learning.
Sharma VJ; Singh A; Grant JL; Raman J
Pathology; 2024 Apr; 56(3):313-321. PubMed ID: 38341306
[TBL] [Abstract] [Full Text] [Related]
[Next]
